Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure

AIMS: Sodium–glucose co‐transporter 2 (SGLT2) inhibitors improve clinical outcome in patients with heart failure (HF), but the mechanisms behind their beneficial effects are not yet fully understood. We examined the effects of empagliflozin on renal sodium and glucose handling in patients with acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Boorsma, Eva M., Beusekamp, Joost C., ter Maaten, Jozine M., Figarska, Sylwia M., Danser, A.H. Jan, van Veldhuisen, Dirk J., van der Meer, Peter, Heerspink, Hiddo J.L., Damman, Kevin, Voors, Adriaan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
Acute Heart Failure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048437/
https://www.ncbi.nlm.nih.gov/pubmed/33251643
http://dx.doi.org/10.1002/ejhf.2066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048437/
https://www.ncbi.nlm.nih.gov/pubmed/33251643
http://dx.doi.org/10.1002/ejhf.2066

Ejemplares similares